Changes over time in the impact of gene-expression profiles on the administration of adjuvant chemotherapy in estrogen receptor positive early stage breast cancer patients: A nationwide study-Reference-Cited by-同舟云学术

Changes over time in the impact of gene-expression profiles on the administration of adjuvant chemotherapy in estrogen receptor positive early stage breast cancer patients: A nationwide study

Published:2016-04-19 Issue:4 Volume:139 Page:769-775
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Kuijer A.¹²,Drukker C.A.³,Elias S.G.⁴,Smorenburg C.H.⁵,Th. Rutgers E.J.⁶,Siesling S.⁷,van Dalen Th.¹

Affiliation:

1. Department of Surgery; Diakonessenhuis Utrecht; the Netherlands

2. Department of Radiology; University Medical Center Utrecht; the Netherlands

3. Department of Surgery; Albert Schweitzer Hospital; Dordrecht the Netherlands

4. Department of Epidemiology; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht; Utrecht the Netherlands

5. Department of Medical Oncology; Antoni Van Leeuwenhoek Hospital - Netherlands Cancer Institute; Amsterdam the Netherlands

6. Department of Surgery; Antoni Van Leeuwenhoek Hospital - Netherlands Cancer Institute; Amsterdam the Netherlands

7. Department of Research; Netherlands Comprehensive Cancer Organization (IKNL); Utrecht the Netherlands

Funder

Dutch Cancer Society (KWF)

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference29 articles.

1. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women;Early Breast Cancer Trialists' Collaborative Group (EBCTCG).;Lancet,1992

2. Effects of chemotherapy and hormonal therapy for early breast cancer recurrence and 15-year survival: an overview of the randomized trials;Lancet,2005

3. Richtlijn mammacarcinoom 2012 81 3

4. Meeting highlights: adjuvant therapy for primary breast cancer;Goldhirsch;J Natl Cancer Inst,1992

5. Meeting highlights: international consensus panel on the treatment of primary breast cancer;Goldhirsch;J Clin Oncol,2001

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer;European Journal of Cancer;2022-11

2. Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer;Breast Cancer Research and Treatment;2021-06-30

3. Use and Impact of the 21-Gene Recurrence Score in Relation to the Clinical Risk of Developing Metastases in Early Breast Cancer Patients in the Netherlands;Public Health Genomics;2018

4. Impact of gene-expression profiling in patients with early breast cancer when applied outside the guideline directed indication area;European Journal of Cancer;2017-10

5. Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor–Positive Early Breast Cancer: Results of a Prospective Cohort Study;Journal of Clinical Oncology;2017-08-20